• Users Online: 36
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2020| July-September  | Volume 7 | Issue 3  
    Online since September 1, 2020

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
REVIEW ARTICLES
Immuno-potentiating effects of Astragalus polysaccharides: A mini-literature review
Hung- Chih Lai, Jo- Pai Chen
July-September 2020, 7(3):99-104
DOI:10.4103/JCRP.JCRP_3_20  
  955 168 -
ORIGINAL ARTICLES
Efficacy and safety of uracil-tegafur in patients with recurrent or metastatic thymic carcinoma
Shih- Yu Huang, Cheng- Hua Huang, Harvey Yu-Li Su, Yen- Hao Chen, Tai- Jan Chiu, Yen- Yang Chen
July-September 2020, 7(3):111-115
DOI:10.4103/JCRP.JCRP_11_20  
  886 143 1
REVIEW ARTICLES
Vascular onco-therapies targeting continuous and intermittent intra-tumor hypoxia
Tanmoy Paul, Sharmita Basu
July-September 2020, 7(3):105-110
DOI:10.4103/JCRP.JCRP_9_20  
  781 112 -
SHORT COMMUNICATION
Management options for gynecological cancers in low- to middle-income countries amidst COVID-19 pandemic
Ashutosh Mishra, MD Ray, Sandeep Bhoriwal, Jyoti Sharma, Chitresh Kumar, Kunal Dhall, Manoj S Gowda, Akash Kumar
July-September 2020, 7(3):121-126
DOI:10.4103/JCRP.JCRP_14_20  
  783 87 -
ORIGINAL ARTICLES
Oncological and renal function outcome in children with unilateral wilms' tumors treated with nephron sparing surgery or ablative nephrectomy
RB Nerli, Manas Sharma, Shridhar C Ghagane, Sreeharsha Nutalapati, Murigendra B Hiremath, Neeraj S Dixit
July-September 2020, 7(3):116-120
DOI:10.4103/JCRP.JCRP_12_20  
  612 98 -
CASE REPORTS
Gemcitabine/cisplatin/pembrolizumab-induced posterior reversible encephalopathy syndrome
Yuh- Ching Gau, Hui- Ching Wang, Hui- Hua Hsiao, Yi- Chang Liu
July-September 2020, 7(3):127-129
DOI:10.4103/JCRP.JCRP_6_20  
  537 92 1
Successfully overcoming carboplatin hypersensitivity by continuous 48-h infusion of cisplatin plus poly (ADP-ribose) polymerase inhibitor for heavily pretreated recurrent ovarian cancer
Yu- Mei Zheng, Jyh- Ming Chow, Chia- Lun Chang, Gi- Ming Lai
July-September 2020, 7(3):134-137
DOI:10.4103/JCRP.JCRP_16_20  
  545 80 1
Primary adenocarcinoma of the urinary bladder: Report of two cases with a literature review
Tsung- Jang Yeh, Shih- Hao Tang, Yi- Chang Liu, Hui- Hua Hsiao
July-September 2020, 7(3):130-133
DOI:10.4103/JCRP.JCRP_17_20  
  522 67 -